Logo image of CGBD

CARLYLE SECURED LENDING INC (CGBD) Stock Fundamental Analysis

USA - NASDAQ:CGBD - US8722801029 - Common Stock

12.39 USD
-0.17 (-1.35%)
Last: 10/22/2025, 8:21:25 PM
12.39 USD
0 (0%)
After Hours: 10/22/2025, 8:21:25 PM
Fundamental Rating

4

Overall CGBD gets a fundamental rating of 4 out of 10. We evaluated CGBD against 236 industry peers in the Capital Markets industry. CGBD has only an average score on both its financial health and profitability. CGBD is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CGBD had positive earnings in the past year.
In the past year CGBD has reported a negative cash flow from operations.
CGBD had positive earnings in each of the past 5 years.
In the past 5 years CGBD always reported a positive cash flow from operatings.
CGBD Yearly Net Income VS EBIT VS OCF VS FCFCGBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

CGBD's Return On Assets of 2.61% is in line compared to the rest of the industry. CGBD outperforms 48.73% of its industry peers.
CGBD has a worse Return On Equity (5.60%) than 61.44% of its industry peers.
The Return On Invested Capital of CGBD (3.14%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for CGBD is below the industry average of 7.56%.
Industry RankSector Rank
ROA 2.61%
ROE 5.6%
ROIC 3.14%
ROA(3y)4.34%
ROA(5y)4.2%
ROE(3y)9.37%
ROE(5y)9.03%
ROIC(3y)4.38%
ROIC(5y)4.06%
CGBD Yearly ROA, ROE, ROICCGBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a decent Profit Margin value of 28.61%, CGBD is doing good in the industry, outperforming 73.31% of the companies in the same industry.
In the last couple of years the Profit Margin of CGBD has grown nicely.
CGBD has a Operating Margin of 42.57%. This is in the better half of the industry: CGBD outperforms 74.58% of its industry peers.
In the last couple of years the Operating Margin of CGBD has remained more or less at the same level.
With a Gross Margin value of 45.47%, CGBD perfoms like the industry average, outperforming 49.15% of the companies in the same industry.
In the last couple of years the Gross Margin of CGBD has remained more or less at the same level.
Industry RankSector Rank
OM 42.57%
PM (TTM) 28.61%
GM 45.47%
OM growth 3Y-3.76%
OM growth 5Y-1.44%
PM growth 3Y-26.26%
PM growth 5Y5.82%
GM growth 3Y-3.2%
GM growth 5Y-0.67%
CGBD Yearly Profit, Operating, Gross MarginsCGBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, CGBD has more shares outstanding
Compared to 5 years ago, CGBD has less shares outstanding
Compared to 1 year ago, CGBD has an improved debt to assets ratio.
CGBD Yearly Shares OutstandingCGBD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CGBD Yearly Total Debt VS Total AssetsCGBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of 0.60, we must say that CGBD is in the distress zone and has some risk of bankruptcy.
CGBD's Altman-Z score of 0.60 is on the low side compared to the rest of the industry. CGBD is outperformed by 61.02% of its industry peers.
CGBD has a Debt/Equity ratio of 1.09. This is a high value indicating a heavy dependency on external financing.
CGBD has a Debt to Equity ratio of 1.09. This is comparable to the rest of the industry: CGBD outperforms 43.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF N/A
Altman-Z 0.6
ROIC/WACCN/A
WACCN/A
CGBD Yearly LT Debt VS Equity VS FCFCGBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 3.55 indicates that CGBD has no problem at all paying its short term obligations.
The Current ratio of CGBD (3.55) is better than 82.63% of its industry peers.
CGBD has a Quick Ratio of 3.55. This indicates that CGBD is financially healthy and has no problem in meeting its short term obligations.
CGBD has a Quick ratio of 3.55. This is amongst the best in the industry. CGBD outperforms 82.63% of its industry peers.
Industry RankSector Rank
Current Ratio 3.55
Quick Ratio 3.55
CGBD Yearly Current Assets VS Current LiabilitesCGBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

3

3. Growth

3.1 Past

The earnings per share for CGBD have decreased strongly by -16.98% in the last year.
CGBD shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.24% yearly.
Looking at the last year, CGBD shows a decrease in Revenue. The Revenue has decreased by -3.69% in the last year.
CGBD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.00% yearly.
EPS 1Y (TTM)-16.98%
EPS 3Y9.58%
EPS 5Y2.24%
EPS Q2Q%-23.53%
Revenue 1Y (TTM)-3.69%
Revenue growth 3Y10.75%
Revenue growth 5Y1%
Sales Q2Q%15.48%

3.2 Future

The Earnings Per Share is expected to decrease by -6.94% on average over the next years.
Based on estimates for the next years, CGBD will show a small growth in Revenue. The Revenue will grow by 5.44% on average per year.
EPS Next Y-19%
EPS Next 2Y-10.47%
EPS Next 3Y-6.94%
EPS Next 5YN/A
Revenue Next Year13.44%
Revenue Next 2Y9.66%
Revenue Next 3Y5.44%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CGBD Yearly Revenue VS EstimatesCGBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
CGBD Yearly EPS VS EstimatesCGBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.04 indicates a rather cheap valuation of CGBD.
Based on the Price/Earnings ratio, CGBD is valued cheaply inside the industry as 85.59% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of CGBD to the average of the S&P500 Index (27.57), we can say CGBD is valued rather cheaply.
A Price/Forward Earnings ratio of 7.73 indicates a rather cheap valuation of CGBD.
CGBD's Price/Forward Earnings ratio is rather cheap when compared to the industry. CGBD is cheaper than 83.47% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.09, CGBD is valued rather cheaply.
Industry RankSector Rank
PE 7.04
Fwd PE 7.73
CGBD Price Earnings VS Forward Price EarningsCGBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CGBD Per share dataCGBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A cheap valuation may be justified as CGBD's earnings are expected to decrease with -6.94% in the coming years.
PEG (NY)N/A
PEG (5Y)3.14
EPS Next 2Y-10.47%
EPS Next 3Y-6.94%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 13.11%, CGBD is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 8.46, CGBD pays a better dividend. On top of this CGBD pays more dividend than 80.08% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, CGBD pays a better dividend.
Industry RankSector Rank
Dividend Yield 13.11%

5.2 History

The dividend of CGBD has a limited annual growth rate of 1.13%.
CGBD has been paying a dividend for over 5 years, so it has already some track record.
CGBD has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)1.13%
Div Incr Years4
Div Non Decr Years4
CGBD Yearly Dividends per shareCGBD Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

CGBD pays out 139.71% of its income as dividend. This is not a sustainable payout ratio.
CGBD's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP139.71%
EPS Next 2Y-10.47%
EPS Next 3Y-6.94%
CGBD Yearly Income VS Free CF VS DividendCGBD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
CGBD Dividend Payout.CGBD Dividend Payout, showing the Payout Ratio.CGBD Dividend Payout.PayoutRetained Earnings

CARLYLE SECURED LENDING INC

NASDAQ:CGBD (10/22/2025, 8:21:25 PM)

After market: 12.39 0 (0%)

12.39

-0.17 (-1.35%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners36%
Inst Owner Change-1.66%
Ins Owners0.42%
Ins Owner Change-1.01%
Market Cap903.23M
Revenue(TTM)234.46M
Net Income(TTM)67.08M
Analysts50
Price Target14.74 (18.97%)
Short Float %0.71%
Short Ratio1.1
Dividend
Industry RankSector Rank
Dividend Yield 13.11%
Yearly Dividend1.89
Dividend Growth(5Y)1.13%
DP139.71%
Div Incr Years4
Div Non Decr Years4
Ex-Date09-30 2025-09-30 (0.4)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.8%
Min EPS beat(2)-7.06%
Max EPS beat(2)-2.53%
EPS beat(4)1
Avg EPS beat(4)-1.34%
Min EPS beat(4)-7.06%
Max EPS beat(4)4.72%
EPS beat(8)4
Avg EPS beat(8)-0.01%
EPS beat(12)7
Avg EPS beat(12)3.46%
EPS beat(16)10
Avg EPS beat(16)4.11%
Revenue beat(2)0
Avg Revenue beat(2)-5.41%
Min Revenue beat(2)-7.79%
Max Revenue beat(2)-3.03%
Revenue beat(4)1
Avg Revenue beat(4)-3.8%
Min Revenue beat(4)-7.79%
Max Revenue beat(4)0.28%
Revenue beat(8)3
Avg Revenue beat(8)-1.96%
Revenue beat(12)5
Avg Revenue beat(12)0.4%
Revenue beat(16)8
Avg Revenue beat(16)0.83%
PT rev (1m)0%
PT rev (3m)3.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.08%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.96%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.72%
Valuation
Industry RankSector Rank
PE 7.04
Fwd PE 7.73
P/S 3.85
P/FCF N/A
P/OCF N/A
P/B 0.75
P/tB 0.75
EV/EBITDA N/A
EPS(TTM)1.76
EY14.21%
EPS(NY)1.6
Fwd EY12.94%
FCF(TTM)-1.84
FCFYN/A
OCF(TTM)-1.84
OCFYN/A
SpS3.22
BVpS16.43
TBVpS16.43
PEG (NY)N/A
PEG (5Y)3.14
Graham Number25.51
Profitability
Industry RankSector Rank
ROA 2.61%
ROE 5.6%
ROCE 3.98%
ROIC 3.14%
ROICexc 3.21%
ROICexgc 3.21%
OM 42.57%
PM (TTM) 28.61%
GM 45.47%
FCFM N/A
ROA(3y)4.34%
ROA(5y)4.2%
ROE(3y)9.37%
ROE(5y)9.03%
ROIC(3y)4.38%
ROIC(5y)4.06%
ROICexc(3y)4.5%
ROICexc(5y)4.2%
ROICexgc(3y)4.5%
ROICexgc(5y)4.2%
ROCE(3y)5.55%
ROCE(5y)5.14%
ROICexgc growth 3Y8.24%
ROICexgc growth 5Y2.47%
ROICexc growth 3Y8.2%
ROICexc growth 5Y2.45%
OM growth 3Y-3.76%
OM growth 5Y-1.44%
PM growth 3Y-26.26%
PM growth 5Y5.82%
GM growth 3Y-3.2%
GM growth 5Y-0.67%
F-Score2
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.43
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.55
Quick Ratio 3.55
Altman-Z 0.6
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)133.13%
Profit Quality(5y)1416.45%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.98%
EPS 3Y9.58%
EPS 5Y2.24%
EPS Q2Q%-23.53%
EPS Next Y-19%
EPS Next 2Y-10.47%
EPS Next 3Y-6.94%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.69%
Revenue growth 3Y10.75%
Revenue growth 5Y1%
Sales Q2Q%15.48%
Revenue Next Year13.44%
Revenue Next 2Y9.66%
Revenue Next 3Y5.44%
Revenue Next 5YN/A
EBIT growth 1Y-10.26%
EBIT growth 3Y6.6%
EBIT growth 5Y-0.46%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-178.83%
FCF growth 3Y11.41%
FCF growth 5YN/A
OCF growth 1Y-178.83%
OCF growth 3Y11.41%
OCF growth 5YN/A